Market cap
$536 Mln
Recently Viewed
Clear AllMarket cap
$536 Mln
Revenue (TTM)
$443 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0 %
ROCE
-- %
Industry P/E
46.58
EV/EBITDA
16.3
Debt to Equity
0.5
Book Value
$--
EPS
$-0.7
Face value
--
Shares outstanding
28,210,715
CFO
$493.28 Mln
EBITDA
$534.27 Mln
Net Profit
$-1,219.76 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ZimVie (ZIMV)
| 36.1 | 0.4 | 125.0 | 29.4 | 39.0 | -- | -- |
|
BSE Sensex*
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
|---|---|---|
|
ZimVie (ZIMV)
| -21.3 | 90.0 |
|
S&P Small-Cap 600
| 7.0 | 13.9 |
|
BSE Sensex
| 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and... biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida. As of October 20, 2025, ZimVie Inc. was taken private. Read more
President, CEO & Director
Mr. Vafa Jamali
President, CEO & Director
Mr. Vafa Jamali
Headquarters
Palm Beach Gardens, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of ZimVie Inc (ZIMV) is $18.99 (NASDAQ) as of 21-Oct-2025 09:30 EDT. ZimVie Inc (ZIMV) has given a return of 39.01% in the last 3 years.
Since, TTM earnings of ZimVie Inc (ZIMV) is negative, P/E ratio is not available.
The P/B ratio of ZimVie Inc (ZIMV) is 1.29 times as on 21-Oct-2025, a 60 discount to its peers’ median range of 3.25 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-14.80
|
1.00
|
|
2023
|
-1.22
|
1.17
|
|
2022
|
-3.82
|
0.32
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of ZimVie Inc (ZIMV) are Rs 19.01 and Rs 8.15 as of 26-Apr-2026.
ZimVie Inc (ZIMV) has a market capitalisation of $ 536 Mln as on 21-Oct-2025. As per SEBI classification, it is a Small Cap company.
Before investing in ZimVie Inc (ZIMV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.